Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Cellular and Molecular Neurobiology|July 8, 2009
Metabolic characterization of a mouse deficient in all known leptin receptor isoformsOlivia Osborn, Manuel Sanchez-Alavez, Sara E Brownell, et al.Psychopharmacology|February 19, 2005
Neuropeptide expression in rats exposed to chronic mild stressesValeriy Sergeyev, Serguei Fetissov, Aleksander A Mathé, et al.Journal of Neurochemistry|April 23, 2013
Novel systemically active galanin receptor 2 ligands in depression-like behaviorIndrek Saar, Jaanus Lahe, Kent Langel, et al.Proceedings of the National Academy of Sciences of the United States of America|July 11, 2003
The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawalVenetia Zachariou, Darlene H Brunzell, Jessica Hawes, et al.Proceedings of the National Academy of Sciences of the United States of America|July 28, 2010
GalR2-positive allosteric modulator exhibits anticonvulsant effects in animal modelsXiaoying Lu, Edward Roberts, Fengcheng Xia, et al.Proceedings of the National Academy of Sciences of the United States of America|February 15, 2008
Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicityJoel N Buxbaum, Zhengyi Ye, Natàlia Reixach, et al.Metabolism: Clinical and Experimental|May 8, 2012
Downregulation of GPR83 in the hypothalamic preoptic area reduces core body temperature and elevates circulating levels of adiponectinJeffrey S Dubins, Manuel Sanchez-Alavez, Victor Zhukov, et al.Plos One|December 15, 2010
Reversal of obesity and insulin resistance by a non-peptidic glucagon-like peptide-1 receptor agonist in diet-induced obese miceMin He, Haoran Su, Weiwei Gao, et al.Neurobiology of Learning and Memory|June 18, 2009
Impairment of memory consolidation by galanin correlates with in vivo inhibition of both LTP and CREB phosphorylationJefferson W Kinney, Manuel Sanchez-Alavez, Alasdair M Barr, et al.Alzheimer'S & Dementia (New York, N. Y.)|January 11, 2020
A blood-based nutritional risk index explains cognitive enhancement and decline in the multidomain Alzheimer prevention trialGene L Bowman, Hiroko H Dodge, Sophie Guyonnet, et al.Pageof 11